Targeting Glutathione Reductase in KEAP1/NRF2 Mutant NSCLC

被引:0
|
作者
Jiang, Chang [1 ]
DeNicola, Gina [2 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Physiol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
D O I
10.1016/j.freeradbiomed.2022.10.186
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
179
引用
收藏
页数:2
相关论文
共 50 条
  • [21] A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants
    Aboulkassim, Tahar
    Tian, Xiaohong
    Liu, Qiang
    Qiu, Dinghong
    Hancock, Mark
    Wu, Jian Hui
    Batist, Gerald
    CELL REPORTS, 2023, 42 (09):
  • [22] Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
    Jarrin Lopez, Alberto
    Lau, Hien
    Li, Shiri
    Ichii, Hirohito
    ANTIOXIDANTS, 2020, 9 (04)
  • [23] miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1
    Akdemir, Burak
    Nakajima, Yasuaki
    Inazawa, Johji
    Inoue, Jun
    MOLECULAR CANCER RESEARCH, 2017, 15 (11) : 1570 - 1578
  • [24] Fragment-based Drug Discovery Targeting KEAP1/Nrf2 Binding
    Zhong, Mengqi
    Lynch, Andrew
    Jehle, Stefan
    Kozakov, Dima
    Vajda, Sandor
    Allen, Karen
    Whitty, Adrian
    FASEB JOURNAL, 2015, 29
  • [25] Fragment-based drug discovery targeting KEAP1/Nrf2 binding
    Zhong, Mengqi
    Lynch, Andrew
    Jehle, Stefan
    Luo, Lingqi
    Kozakov, Dmytro
    Whitty, Adrian
    Allen, Karen
    Vajda, Sandor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [26] MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression
    Kabaria, Sayan
    Choi, Doo Chul
    Chaudhuri, Amrita Datta
    Jain, Mohit Raja
    Li, Hong
    Junn, Eunsung
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 89 : 548 - 556
  • [27] Building a Better Nrf2 Activator: Targeting Keap1 Cysteine 151 with Electrophiles
    Allender, Amanda
    Zhai, Tianhua
    Huang, Zuyi
    Eggler, Aimee
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 192
  • [28] Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
    Zhang, Shunhao
    Duan, Sining
    Xie, Zhuojun
    Bao, Wanlin
    Xu, Bo
    Yang, Wenbin
    Zhou, Lingyun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling
    Lo, Shih-Ching
    Li, Xuchu
    Henzl, Michael T.
    Beamer, Lesa J.
    Hannink, Mark
    EMBO JOURNAL, 2006, 25 (15): : 3605 - 3617